These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 8834174

  • 1. Alterations of the retinoblastoma gene in human prostate adenocarcinoma.
    Tricoli JV, Gumerlock PH, Yao JL, Chi SG, D'Souza SA, Nestok BR, deVere White RW.
    Genes Chromosomes Cancer; 1996 Feb; 15(2):108-14. PubMed ID: 8834174
    [Abstract] [Full Text] [Related]

  • 2. The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
    Kuczyk MA, Serth J, Bokemeyer C, Schwede J, Herrmann R, Machtens S, Grünewald V, Höfner K, Jonas U.
    Oncol Rep; 1998 Feb; 5(1):213-6. PubMed ID: 9458379
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
    Wang JC, Bégin LR, Bérubé NG, Chevalier S, Aprikian AG, Gourdeau H, Chevrette M.
    Clin Cancer Res; 2007 Apr 15; 13(8):2354-61. PubMed ID: 17406028
    [Abstract] [Full Text] [Related]

  • 4. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.
    Latil A, Chêne L, Mangin P, Fournier G, Berthon P, Cussenot O.
    Prostate; 2003 Sep 15; 57(1):39-50. PubMed ID: 12886522
    [Abstract] [Full Text] [Related]

  • 5. Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
    Chi SG, deVere White RW, Muenzer JT, Gumerlock PH.
    Clin Cancer Res; 1997 Oct 15; 3(10):1889-97. PubMed ID: 9815578
    [Abstract] [Full Text] [Related]

  • 6. Studies of the RB1 gene and the p53 gene in human osteosarcomas.
    Scholz RB, Kabisch H, Weber B, Röser K, Delling G, Winkler K.
    Pediatr Hematol Oncol; 1992 Oct 15; 9(2):125-37. PubMed ID: 1524989
    [Abstract] [Full Text] [Related]

  • 7. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H, Gemma A, Hosoya Y, Matsuda K, Nara M, Hosomi Y, Okano T, Kurimoto F, Seike M, Takenaka K, Yoshimura A, Toyota M, Kudoh S.
    Mol Carcinog; 2003 Nov 15; 38(3):124-9. PubMed ID: 14587097
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
    Malekzadeh K, Sobti RC, Nikbakht M, Shekari M, Hosseini SA, Tamandani DK, Singh SK.
    Cancer Invest; 2009 Jan 15; 27(1):70-80. PubMed ID: 19160091
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A, Xiao N, Kang J, Best CJ, Leiva I, Emmert-Buck MR, Jorcyk C, Green JE.
    Cancer Res; 2002 Sep 15; 62(18):5325-35. PubMed ID: 12235003
    [Abstract] [Full Text] [Related]

  • 14. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer.
    Chen C, Bhalala HV, Vessella RL, Dong JT.
    Prostate; 2003 May 01; 55(2):81-8. PubMed ID: 12661032
    [Abstract] [Full Text] [Related]

  • 15. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP, Yang GY, Wang LD, Shi ST, Yang CS.
    Clin Cancer Res; 1999 May 01; 5(5):1231-40. PubMed ID: 10353761
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
    Davis JN, Wojno KJ, Daignault S, Hofer MD, Kuefer R, Rubin MA, Day ML.
    Cancer Res; 2006 Dec 15; 66(24):11897-906. PubMed ID: 17178887
    [Abstract] [Full Text] [Related]

  • 20. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 15; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.